COR

Cencora Inc

303.07

Jul 21 • 03:59PM ET -0.92 (-0.30%)

303.07

Aftermarket • 07:34PM ET 0.00 (0.00%)

Healthcare Medical Distribution USA Large NYSE

Peers: CAH MCK MDLN HSIC CVS UNH CI ELV HUM AHG

| Held by: VTI VOO VO IVV SPY VTV XLV VOE IWP VIG

Scroll to Statements

Index	S&P 500
Market Cap	58.97B
Enterprise Value	69.30B
Income	2.55B
Sales	328.68B
Book/sh	17.46
Cash/sh	11.49
Dividend Est.	2.37 (0.78%)
Dividend TTM	2.35 (0.78%)
Dividend Ex-Date	May 15, 2026
Dividend Gr. 3/5Y	6.14% 5.79%
Payout	27.63%
Employees	51000
IPO	Apr 04, 1995

P/E	23.25
Forward P/E	15.29
PEG	1.36
P/S	0.18
P/B	17.36
P/C	26.37
P/FCF	37.84
EV/EBITDA	13.26
EV/Sales	0.21
Quick Ratio	0.59
Current Ratio	0.95
Debt/Eq	3.65
LT Debt/Eq	3.59
Option/Short	Yes / Yes

EPS (ttm)	13.03
EPS next Y	19.83
EPS next Q	4.34
EPS this Y	11.13%
EPS next Y	11.50%
EPS next 5Y	11.27%
EPS past 3/5Y	-0.34% -
Sales past 3/5Y	10.43% 11.09%
EPS Y/Y TTM	51.04%
Sales Y/Y TTM	5.95%
EPS Q/Q	128.30%
Sales Q/Q	3.85%
Earnings	Aug 05 BMO
EPS/Sales Surpr.	-1.42% -3.37%

Insider Own	0.49%
Insider Trans	-0.17%
Inst Own	99.24%
Inst Trans	0.60%
ROA	3.33%
ROE	115.58%
ROIC	16.36%
Gross Margin	3.46%
Oper. Margin	1.27%
Profit Margin	0.78%
SMA20	2.14%
SMA50	8.10%
SMA200	-6.61%
Trades

Shs Outstand	194.56M
Shs Float	193.61M
Short Float	2.84%
Short Ratio	2.99
Short Interest	5.50M
52W High	377.54 -19.73%
52W Low	244.82 23.79%
Volatility	2.38% 2.47%
ATR (14)	7.39
RSI (14)	58.36
Beta	0.57
Rel Volume	0.72
Avg Volume	1.84M
Volume	1,324,680

Perf Week	0.26%
Perf Month	11.49%
Perf Quarter	-6.17%
Perf Half Y	-14.59%
Perf YTD	-10.27%
Perf Year	3.55%
Perf 3Y	57.37%
Perf 5Y	156.36%
Perf 10Y	253.19%
Recom	1.61
Target Price	354.83
Prev Close	303.99
Price	303.07
Change	-0.30%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-28-26	Initiated	William Blair	Mkt Perform
Jan-29-26	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$400
Jan-22-26	Upgrade	Jefferies	Hold → Buy	$440
Dec-09-25	Initiated	Barclays	Overweight	$400
Jun-03-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$337
Dec-04-24	Resumed	Mizuho	Outperform	$280
Sep-18-24	Downgrade	BofA Securities	Buy → Neutral	$275 → $245
Feb-26-24	Initiated	Leerink Partners	Outperform	$261
Jan-03-24	Initiated	Barclays	Overweight	$242
Dec-14-23	Initiated	Wells Fargo	Equal Weight	$213
Mar-31-23	Initiated	Citigroup	Buy	$185
Jan-31-23	Resumed	Evercore ISI	Outperform	$185
Oct-11-22	Upgrade	BofA Securities	Neutral → Buy	$160 → $169
Aug-22-22	Resumed	Morgan Stanley	Equal-Weight
Jul-11-22	Downgrade	Evercore ISI	Outperform → In-line	$150
Jun-07-22	Upgrade	Deutsche Bank	Hold → Buy	$167 → $178
May-26-22	Upgrade	Barclays	Equal Weight → Overweight
Apr-12-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$178
Apr-01-22	Resumed	Credit Suisse	Outperform	$180
Feb-04-21	Upgrade	Evercore ISI	In-line → Outperform

Show Previous Ratings

Jul-09-26 09:24AM	McKesson Stock Is Shrinking, and That's The Point for Owners (Trefis)
Jul-08-26 02:24PM	McKesson Stock Is Shrinking, And That's The Point (Trefis)
Jul-01-26 04:30PM	Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release (Business Wire)
Jun-15-26 04:15PM	Cencora Announces Samantha Hammock as Chief Human Resources Officer (Business Wire)
May-27-26 07:14AM	Cencora nabs ex-CVS exec as new CFO (Healthcare Dive)
06:55AM	Loading…
06:55AM	Cencora Appoints Eva Boratto as Executive Vice President and Chief Financial Officer (Business Wire)
May-21-26 04:30PM	Cencora Announces Updated Fiscal Year 2026 Financial Outlook (Business Wire)
May-06-26 12:48PM	Cencora, Inc. Q2 2026 Earnings Call Summary (Moby) -17.38%
06:48AM	Cencora: Fiscal Q2 Earnings Snapshot (Associated Press)
06:30AM	Cencora Reports Fiscal 2026 Second Quarter Results (Business Wire)
Apr-30-26 12:30AM	2 Things Matter Most in Picking Winning Stocks, Says This Market Pro (Barrons.com)
Apr-20-26 12:12PM	McKesson Stock: A Compounding Engine Facing Its Critical Test (Trefis)
Apr-01-26 04:30PM	Cencora Announces Date and Time for Second Quarter Fiscal 2026 Earnings Release (Business Wire)
Mar-24-26 05:19AM	Cencora to buy EyeSouths retina business for $1.1B (Healthcare Dive)
Mar-23-26 07:00AM	Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners Retina Business (Business Wire)
04:36PM	Loading…
Mar-17-26 04:36PM	Stock Indexes Advance as Chip Makers and Travel Stocks Rally (Barchart)
11:17AM	Stocks Climb on Strength in Chip and Travel Stocks (Barchart)
10:15AM	Stocks Supported by Lower Bond Yields (Barchart)
08:30AM	Cencora Announces Financial Leadership Transition (Business Wire)
05:32AM	Cencora CFO announces retirement (Healthcare Dive)
Mar-13-26 04:41PM	How Cardinal Health, The IBD Stock Of The Day, Is Navigating The Tricky Macro (Investor's Business Daily)
Mar-06-26 07:12PM	Analyst Report: McKesson Corporation (Morningstar Research)
11:30AM	Why Is Cencora (COR) Up 2% Since Last Earnings Report? (Zacks)
07:26AM	Is Cencora Stock Outperforming the S&P 500? (Barchart)
Mar-02-26 04:31AM	Is McKesson Corporation Stock Outperforming the Nasdaq? (Barchart)
Feb-26-26 07:12PM	Analyst Report: McKesson Corporation (Morningstar Research)
Feb-19-26 07:56AM	COR's MWI Animal Health to Merge With Covetrus in $3.5 Billion Deal (Zacks)
Feb-18-26 07:00AM	Covetrus and MWI Animal Health to Merge (Business Wire)
Feb-17-26 08:52AM	Is the Options Market Predicting a Spike in Cencora Stock? (Zacks)
Feb-13-26 04:15PM	Cencora Closes $3.0 Billion Senior Notes Offering (Business Wire)
03:51PM	Loading…
03:51PM	Cencora, Azenta, The Pennant Group, LifeStance Health Group, and Gilead Sciences Shares Are Soaring, What You Need To Know (StockStory)
Feb-11-26 11:37PM	1 Momentum Stock with Impressive Fundamentals and 2 We Question (StockStory)
12:36AM	5 Revealing Analyst Questions From Cencora's Q4 Earnings Call (StockStory)
Feb-10-26 05:15PM	Cencora Prices $500 Million 3.950% Senior Notes Due 2029, $500 Million 4.250% Senior Notes Due 2030, $500 Million 4.600% Senior Notes Due 2033, $1.0 Billion 4.900% Senior Notes Due 2036 and $500 Million 5.650% Senior Notes Due 2056 (Business Wire)
07:31AM	What Are Wall Street Analysts' Target Price for Cencora Stock? (Barchart)
Feb-06-26 09:28AM	Low Volatility ETFs to Watch Amid Major Tech Sell-Off Over AI Panic (Zacks)
Feb-05-26 03:31PM	Cencora (COR) Stock Trades Up, Here Is Why (StockStory) +6.72%
01:58PM	Analyst Report: Cardinal Health, Inc. (Morningstar Research)
12:48PM	Cardinal Health Stock Jumps After Earnings. Its CEO Explains What Went Right. (Barrons.com)
10:35AM	Analyst Report: McKesson Corporation (Morningstar Research)
01:13AM	Cencora Q1 Earnings Call Highlights (MarketBeat)
12:34AM	COR Q4 Deep Dive: Specialty Expansion and OneOncology Drive Strategic Shifts (StockStory)
Feb-04-26 11:42PM	Analyst Report: McKesson Corporation (Morningstar Research) -8.79%
04:05PM	Cencora Inc (COR) Q1 2026 Earnings Call Highlights: Strong US Growth Amid International Challenges (GuruFocus.com)
01:44PM	Analyst Report: Cencora, Inc. (Morningstar Research)
11:59AM	Cencora Stock Down Despite Q1 Earnings Beat, Gross Margin Improves (Zacks)
11:32AM	Cencora Lifts 2026 Sales Outlook Despite Q1 Revenue Miss (Benzinga)
11:12AM	Rotation out of Tech Stocks Weighs on the Broader Market (Barchart)
10:04AM	Cencora (COR) Q1 2026 Earnings Call Transcript (Motley Fool)
10:03AM	Stocks Mixed on Sector Rotation out of Tech (Barchart)
09:30AM	Cencora (COR) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
07:40AM	Cencora (COR) Q1 Earnings Top Estimates (Zacks)
06:47AM	Cencora (NYSE:COR) Misses Q4 CY2025 Revenue Estimates (StockStory)
06:38AM	Cencora: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
06:30AM	Cencora Reports Fiscal 2026 First Quarter Results (Business Wire)
Feb-02-26 10:06PM	Cencora (COR) Reports Earnings Tomorrow: What To Expect (StockStory)
Feb-01-26 07:47AM	January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week (Yahoo Finance)
Jan-31-26 09:36AM	Analysts Lift Ratings and Price Targets as Cencora, Inc. (COR)'s Growth Story Gains Momentum (Insider Monkey)
Jan-30-26 09:15AM	Exploring Analyst Estimates for Cencora (COR) Q1 Earnings, Beyond Revenue and EPS (Zacks)
Jan-29-26 09:35AM	First Solar downgraded, Fortinet upgraded: Wall Street's top analyst calls (The Fly)
08:33AM	Can Specialty and International Momentum Support Cencora's Q1 Results? (Zacks)
Jan-27-26 08:09PM	Analyst Report: Cencora, Inc. (Morningstar Research)
Jan-26-26 01:27PM	IBD Stock Of The Day: Why Cardinal Health's Momentum Is 'Special' And Not Over Yet (Investor's Business Daily)
Jan-25-26 04:46AM	Here Are the Top Four Blue-Chip Stocks To Buy in 2026, According to WarrenAI (Investing.com)
Jan-22-26 07:30AM	Cencora Elects Ellen Cooper to Its Board of Directors (Business Wire)
Jan-12-26 07:51AM	3 Medical Supplies Stocks That Beat the Market Despite Macro Headwinds (Zacks)
Jan-09-26 09:06AM	What to Expect From Cencora's Next Quarterly Earnings Report (Barchart)
Jan-08-26 08:40PM	Analyst Report: Cencora, Inc. (Morningstar Research)
09:40AM	Why Cencora (COR) is a Top Value Stock for the Long-Term (Zacks)
07:57AM	Here's Why You Should Retain Cencora Stock in Your Portfolio Now (Zacks)
Jan-07-26 09:45AM	Here's Why Cencora (COR) is a Strong Growth Stock (Zacks)
Jan-06-26 04:30PM	Cencora Announces Date and Time for First Quarter Fiscal 2026 Earnings Release (Business Wire)
Jan-05-26 01:44PM	McKesson Builds Earnings Momentum on Specialty and Automation (Zacks)
Dec-30-25 07:33AM	Reasons to Add Cooper Companies Stock to Your Portfolio Now (Zacks)
Dec-29-25 10:17AM	Take the Zacks Approach to Beat the Markets: Castle Biosciences, Hamilton Insurance & Monster Beverage in Focus (Zacks)
08:52AM	Here's Why You Should Retain Glaukos Stock in Your Portfolio Now (Zacks)
Dec-26-25 07:18AM	Reasons to Retain Baxter International Stock in Your Portfolio Now (Zacks)
Dec-24-25 10:36PM	Q3 Rundown: Cencora (NYSE:COR) Vs Other Health Insurance Providers Stocks (StockStory)
09:11AM	These 3 Medical Stocks Have Wall Street's Bullish Vote for 2026 (Zacks)
Dec-23-25 02:09PM	Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now (Zacks)
09:35AM	Zacks.com featured highlights include NVIDIA, Ralph Lauren, Expedia and Cencora (Zacks)
Dec-22-25 10:40AM	4 Stocks Trading Near 52-Week High With More Upside Potential (Zacks)
Dec-19-25 02:14PM	Jim Cramer Says "I like Cencora A Lot" But Notes "Cardinal Health's Got Them All Beat" (Insider Monkey)
11:05AM	Cencora to Acquire OneOncology to Expand Community Oncology Solutions (Zacks)
Dec-18-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Dec-17-25 09:45AM	Why Cencora (COR) is a Top Growth Stock for the Long-Term (Zacks)
Dec-16-25 03:52AM	Cencora takes majority stake in cancer care platform OneOncology for $5B (Healthcare Dive)
Dec-15-25 08:01PM	Lightning Round: Sell BP, says Jim Cramer (CNBC TV)
02:50PM	Analyst Report: Cencora, Inc. (Morningstar Research)
09:06AM	Take the Zacks Approach to Beat the Markets: Liquidia, Western Digital & Johnson & Johnson in Focus (Zacks)
07:00AM	Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology (Business Wire)
Dec-10-25 08:59AM	Here's Why You Should Add Cencora Stock to Your Portfolio Now (Zacks)
Dec-09-25 09:40AM	Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year? (Zacks)
Dec-05-25 11:30AM	Why Is Cencora (COR) Down 6.3% Since Last Earnings Report? (Zacks)
Dec-03-25 03:26PM	Why Cencora (COR) Shares Are Trading Lower Today (StockStory)
02:59PM	JPMorgan Raises Cencora (COR) Price Target After Financial Model Update (Insider Monkey)
03:35AM	How Is Cencoras Stock Performance Compared to Other Medical Stocks? (Barchart)
Dec-02-25 12:00PM	Cencora (COR) Upgraded to Buy: Here's Why (Zacks)
09:40AM	Here's Why Cencora (COR) is a Strong Value Stock (Zacks)
Dec-01-25 09:45AM	Here's Why Cencora (COR) is a Strong Growth Stock (Zacks)

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

PharmDDr. Robert P. Mauch Ph.D.

Executive VP & Chief Legal OfficerMs. Elizabeth S. Campbell J.D.

Executive VP & CFOMs. Eva C. Boratto

Senior VPMr. Lazarus Krikorian

Executive VP and Chief Data & Information OfficerMr. Pawan Singh Verma

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Tyler Lauren M	Director	Jun 22 '26	Buy	270.23	550	148,626	4,359	Jun 24 04:04 PM
DURCAN DERMOT MARK	Director	Jun 18 '26	Buy	274.19	4,000	1,096,760	31,767	Jun 22 04:05 PM
DURCAN DERMOT MARK	Director	May 28 '26	Buy	266.26	4,000	1,065,040	27,767	May 28 04:23 PM
Battaglia Silvana	Executive Vice President	Mar 11 '26	Option Exercise	0.00	8,415	0	27,239	Mar 13 04:17 PM
Campbell Elizabeth S	Executive Vice President	Mar 11 '26	Option Exercise	0.00	12,623	0	36,548	Mar 13 04:16 PM
Cleary James F	Chief Financial Officer	Mar 11 '26	Option Exercise	0.00	12,623	0	165,766	Mar 13 04:14 PM
Mauch Robert P.	President & CEO	Feb 20 '26	Option Exercise	86.09	3,762	323,871	69,155	Feb 24 04:04 PM
Mauch Robert P.	President & CEO	Feb 20 '26	Sale	358.94	3,762	1,350,332	65,393	Feb 24 04:04 PM
Mauch Robert P.	President & CEO	Feb 18 '26	Sale	359.46	1,333	479,160	65,393	Feb 20 04:00 PM
Mauch Robert P.	Officer	Feb 20 '26	Proposed Sale	358.94	3,762	1,350,332		Feb 20 12:27 PM
Mauch Robert P.	Officer	Feb 18 '26	Proposed Sale	359.46	1,333	479,160		Feb 18 11:03 AM
Mauch Robert P.	President & CEO	Jan 20 '26	Option Exercise	86.09	3,763	323,957	71,822	Jan 22 04:43 PM
Mauch Robert P.	President & CEO	Jan 20 '26	Sale	354.73	5,096	1,807,704	66,726	Jan 22 04:43 PM
Mauch Robert P.	Officer	Jan 20 '26	Proposed Sale	354.73	5,096	1,807,704		Jan 20 11:14 AM
Battaglia Silvana	Executive Vice President	Dec 19 '25	Sale	345.00	1,677	578,565	18,796	Dec 22 04:15 PM
Campbell Elizabeth S	Executive Vice President	Dec 19 '25	Sale	342.10	3,351	1,146,377	23,891	Dec 22 04:15 PM
Mauch Robert P.	President & CEO	Dec 18 '25	Option Exercise	86.09	3,763	323,957	73,155	Dec 22 04:14 PM
Mauch Robert P.	President & CEO	Dec 18 '25	Sale	343.45	5,096	1,750,221	68,059	Dec 22 04:14 PM
Campbell Elizabeth S	Officer	Dec 19 '25	Proposed Sale	342.10	3,351	1,146,377		Dec 19 04:15 PM
Krikorian Lazarus	SVP & Chief Accounting Officer	Dec 17 '25	Sale	343.24	4,031	1,383,580	17,154	Dec 19 04:04 PM
Cleary James F	Chief Financial Officer	Dec 17 '25	Option Exercise	86.09	45,154	3,887,308	180,095	Dec 19 04:03 PM
Battaglia Silvana	Officer	Dec 19 '25	Proposed Sale	345.00	1,677	578,565		Dec 19 11:03 AM
Mauch Robert P.	Officer	Dec 18 '25	Proposed Sale	343.45	5,096	1,750,221		Dec 18 09:48 AM
Krikorian Lazarus	Officer	Dec 17 '25	Proposed Sale	343.24	4,031	1,383,580		Dec 17 03:55 PM
Mauch Robert P.	President & CEO	Nov 18 '25	Option Exercise	86.09	3,763	323,957	70,842	Nov 19 05:09 PM
Mauch Robert P.	President & CEO	Nov 18 '25	Sale	366.64	5,096	1,868,397	65,746	Nov 19 05:09 PM
Mauch Robert P.	Officer	Nov 18 '25	Proposed Sale	366.64	5,096	1,868,397		Nov 18 11:43 AM
COLLIS STEVEN H	Former Officer & Director	Nov 18 '25	Proposed Sale	366.64	31,349	11,493,797		Nov 18 10:40 AM
COLLIS STEVEN H	Former Officer & Director	Nov 06 '25	Proposed Sale	355.25	50,000	17,762,554		Nov 06 04:16 PM
Verma Pawan	EVP, Chief Data & Info Officer	Oct 31 '25	Option Exercise	337.81	8,537	2,883,884	8,551	Nov 04 04:15 PM
Mauch Robert P.	President & CEO	Oct 20 '25	Option Exercise	86.09	3,763	323,957	43,037	Oct 21 04:33 PM
Mauch Robert P.	President & CEO	Oct 20 '25	Sale	326.80	5,097	1,665,700	37,940	Oct 21 04:33 PM
COLLIS STEVEN H	Former Officer & Director	Oct 21 '25	Proposed Sale	326.99	31,350	10,251,105		Oct 21 04:16 PM
Mauch Robert P.	Officer	Oct 20 '25	Proposed Sale	326.80	5,097	1,665,700		Oct 20 09:36 AM
Campbell Elizabeth S	Executive Vice President	Oct 01 '25	Sale	313.28	1,886	590,846	12,824	Oct 03 04:01 PM
Campbell Elizabeth S	Officer	Oct 01 '25	Proposed Sale	313.28	1,886	590,846		Oct 01 10:36 AM
Mauch Robert P.	President & CEO	Sep 18 '25	Option Exercise	86.09	3,763	323,957	44,371	Sep 22 04:16 PM
Mauch Robert P.	President & CEO	Sep 18 '25	Sale	290.00	5,097	1,478,130	39,274	Sep 22 04:16 PM
COLLIS STEVEN H	Executive Chairman	Sep 16 '25	Option Exercise	86.09	29,350	2,526,742	337,263	Sep 18 03:56 PM
COLLIS STEVEN H	Executive Chairman	Sep 16 '25	Sale	289.86	31,350	9,087,142	305,913	Sep 18 03:56 PM
Mauch Robert P.	Officer	Sep 18 '25	Proposed Sale	290.00	5,097	1,478,130		Sep 18 11:54 AM
COLLIS STEVEN H	Director	Sep 16 '25	Proposed Sale	291.55	31,350	9,140,092		Sep 16 10:27 AM
COLLIS STEVEN H	Executive Chairman	Aug 19 '25	Option Exercise	86.09	12,579	1,082,926	322,492	Aug 20 04:08 PM
COLLIS STEVEN H	Executive Chairman	Aug 19 '25	Sale	289.98	14,579	4,227,618	307,913	Aug 20 04:08 PM
Mauch Robert P.	President & CEO	Aug 18 '25	Option Exercise	86.09	3,225	277,640	45,576	Aug 20 04:06 PM
Mauch Robert P.	President & CEO	Aug 18 '25	Sale	293.53	4,968	1,458,257	40,608	Aug 20 04:06 PM
COLLIS STEVEN H	Director	Aug 19 '25	Proposed Sale	289.98	14,579	4,227,618		Aug 19 09:51 AM
Mauch Robert P.	Officer	Aug 18 '25	Proposed Sale	293.53	4,968	1,458,257		Aug 18 11:06 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

COR

Cencora Inc

Upgrade your Finviz experience